Back to Assenagon Asset Management S.A. Assenagon Asset Management S.A.

TXGTXG

Showing 8 of 11 quarters

Position history for Assenagon Asset Management S.A.Assenagon Asset Management S.A.'s holdings in 10x Genomics, Inc.

Yes. Assenagon Asset Management holds 22,218 shares of TXG (10x Genomics), worth $2M, as of its Q3 2026 13F filing. It increased the position by 7,641 shares (+52.4%) from Q2 2026. Assenagon Asset Management has held TXG since Q4 2024, across 8 quarterly 13F filings.

Current Value

$2M

Current Shares

22,218

Total Value Change

-$24.3M

Total Shares Change

-1.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
22,218
+52.4%
$2M0.0%$90.36
36
2026-Q2
Unchanged
14,577
0.0%
$558,8820.0%$38.34
0
2026-Q1
Decreased
14,577
-16.4%
$309,4700.0%$21.23
0
2025-Q4
Increased
17,436
+19.6%
$284,3810.0%$16.31
28
2025-Q3
Decreased
14,577
-99.2%
$170,4050.0%$11.69
0
2025-Q2
Decreased
1.7M
-1.3%
$19.8M0.0%$11.58
0
2025-Q1
Decreased
1.7M
-5.3%
$15.1M0.0%$8.73
0
2024-Q4
New
1.8M
—
$26.3M0.0%$14.36
40

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used